The largest database of trusted experimental protocols

54 protocols using alpha mem

1

Osteoclast Differentiation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Non-confluent culture of RAW 264.7 osteoclast precursor (RAW) cell line (from ATCC) was harvested and cultured with minimum essential medium eagle alpha modification (alpha-MEM) (Sigma, St. Louis, MO, USA) supplemented with 2.2 G.L−1 NaHCO3 (Sigma), 15% fetal calf serum (Altana, Lawrenceville, GA, USA), 1% penicillin/streptomycin (1000 U/mL) (Invitrogen, Grand Island, NY, USA), 1% MEM amino acids solution (Invitrogen), 1% L-glutamine (Invitrogen) and 0.1% gentamycin (Invitrogen). Cells (2×105) were cultured in a 24-well plate (Corning, New York, NY, USA) with capillaries with or without MTA, for 24 hours for cell viability assay. Another culture was performed, including 2-capillaries/well with or without MTA, for 24 hours. In order to observe osteoclast differentiation, 100ng.mL−1 of recombinant (r) RANKL (Peprotech, Rock Hill, NJ, USA) was added to this culture, and every three days, half of medium and rRANKL (Peprotech) were changed, and the cultures were harvested on days 5, 6 and 8. RNA extractions were performed after 48h of cell incubation. The evaluation of the effect of aluminum and calcium on osteoclastogenesis was performed through RAW cells incubation with or without 40μg.mL−1 of aluminum oxide, 99.99% (Sigma) and calcium oxide Reagent Plus, 99.99% (Sigma), with/without rRANKL for 7 days.
+ Open protocol
+ Expand
2

Osteoblast Matrix Formation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A mouse calvarial pre-osteoblastic cell line, MC3T3-E1 (MC) subclone 4, was obtained from the American Type Culture Collection (ATCC) (Manassas, VA, USA) and maintained in alpha-minimum essential medium (alpha-MEM) (Life Technologies, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin at 37°C in a humidified atmosphere with 5% CO2. The culture medium was replaced twice a week. MC cells were seeded onto 35-mm dishes at a density of 2 × 105 cells/dish. After 2 days, the medium was replaced with the matrix formation medium (alpha-MEM supplemented with 10% FBS, 1% penicillin/streptomycin, and 50 μg/mL of ascorbic acid (Sigma-Aldrich, St. Louis, MO, USA)), with or without β-aminopropionitrile (BAPN) (0–2 mM; Tokyo Chemical Ind., Co., Ltd, Tokyo, Japan), and cultured for 2 weeks. The cell-matrix layers were washed with ice cold phosphate buffered saline (PBS) three times and stored at -20°C. The matrices were processed for biochemical/histological analyses or used for cell culture substrates as outlined below.
+ Open protocol
+ Expand
3

Culturing Primary Sarcoma and Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Established MG-63, U2os and Ost cell lines were obtained from American Type Culture Collection (ATCC) and cultured in Dulbecco’s Modified Eagle’s Medium (DMEM; Sigma) supplemented with 10% fetal bovine serum (FBS; Sigma), L-glutamine (4 mmol/L), 100 U/mL penicillin and 100 μg/mL streptomycin (all from Invitrogen) at 37°C with 5% CO2. For primary sarcoma cells, specimens were obtained in accordance with Research Ethics Board approval from the Italian National Institute of Cancer G. Pascale and classified according to World Health Organization guidelines. Primary GCTB cell line derived from patients were freshly isolated as previously described [19 (link), 20 (link)] and grown in alpha-MEM (Sigma) supplemented with 10% FBS plus antibiotics. The experiments were performed in alpha-MEM plus 1% WF or 2% FBS (low serum) or 1% Benign effusion.
+ Open protocol
+ Expand
4

Osteoblast-Bone Marrow Co-culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary osteoblast isolated from DicergtRosaCreERT2 mice were seeded as 8,000 cells per well in 96-well plates and treated with 1μM 4-OHT for 3 days as described above. Bone marrow cells from wild-type mice were isolated and 200,000 cells per well were added on top of primary osteoblasts cultivated in alpha-MEM supplemented with 10 nM 1,25-dihydroxyvitamin D3 (Sigma-Aldrich, St. Louis, USA). Medium was changed every 3 days. After 9 days, cells were fixed and stained for TRAP activity.
+ Open protocol
+ Expand
5

Osteoclast Differentiation and Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pZen cell line [12 (link)] was a generous gift from Dr. Larry Rohrschneider. pZen cells were routinely grown in alpha-MEM (Sigma-Aldrich, St. Louis, MO) supplemented with 10% FBS (Atlanta Biologicals, Lawrenceville, GA) and 1% penicillin/streptomycin (GIBCO, Grand Island, NY). To prepare osteoclasts, bone marrow was harvested from C57 BL/6J mice and cultured overnight in α-MEM containing 10% FBS. Non-adherent cells were harvested, layered onto an equivalent volume of Phycol-Hypaque and centrifuged at 700×g for 20 min. Cells at the interface were collected, washed twice in PBS, and plated at a final concentration of 4 × 105 cells/well in 6-well plates in α-MEM containing 10% FBS, 50 ng/mL CSF1 and 100 ng/mL RANKL for 5 days to induce osteoclasts. At day 5, osteoclasts were washed twice in PBS, then treated with 200 ng/mL CSF1 and 100 ng/mL RANKL or, as a control, 50 ng/mL CSF1 and 100 ng/mL RANKL in fresh α-MEM containing 10% FBS for 24 h.
+ Open protocol
+ Expand
6

Cell Culture Conditions for Comparative Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Macrophages RAW 264.7 (TIB-71), pre-osteoblasts MC3T3-E1 subclone 4 (CRL-2593), and kidney MDCK cells (CCL-34) were purchased from the American Type Culture Collection (ATCC). Pre-osteoblast MC3T3-E1 were cultured in alpha-Minimum Essential Medium Eagle Medium (alpha-MEM, Sigma-Aldrich, St. Louis, MO, USA), and both macrophage and kidney cells were propagated in Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma-Aldrich, St. Louis, MO, USA). All culture media were supplemented with 10% fetal bovine serum (FBS, BenchMark, Gemini Bio Products, Sacramento, CA, USA), 1% penicillin streptomycin (Sigma-Aldrich, St. Louis, MO, USA), 1% L-glutamine (BenchMark Gemini Bio Products, Sacramento, CA, USA), and 1.5 g/L sodium bicarbonate (Sigma-Aldrich St. Louis, MO, USA), and incubated until confluence at 37 °C in a 5% CO2 atmosphere.
+ Open protocol
+ Expand
7

Osteotropic Breast Cancer Cell Line

Check if the same lab product or an alternative is used in the 5 most similar protocols
The parental human MDA-MB-231 (MDA-231) as representative of triple-negative breast cancer cells and human osteoblast-like cells Saos-2 were purchased from ATCC (Manassas, VA). The osteotropic MDA-231-BT1 was generated by repeated passages in vivo and validated for their ability to colonize bone and to cause osteolysis47 (link). Tissue culture medium (DMEM and alpha-MEM) was obtained Sigma-Aldrich (Dorset, UK). All primary antibodies were purchased from Cell Signalling Biotechnology (MA, USA) except rabbit anti-actin was obtained from Sigma-Aldrich (Dorset, UK). Mouse macrophage colony stimulating factor (M-CSF) was obtained from R&D Systems (Abingdon, UK) and receptor activator of NFκB ligand (RANKL) was a gift from Patrick Mollat (Galapagos SASU, France).
+ Open protocol
+ Expand
8

Culturing MG63 Osteosarcoma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The osteosarcoma cell line MG63 was procured from National Centre for Cell Science, Pune. Cells were routinely cultured and maintained in alpha-MEM (Sigma Aldrich) + 10% FBS (Heat inactivated, Gibco) at 37 °C and 5% CO2.
+ Open protocol
+ Expand
9

In vitro Erythropoiesis and VCN Determination

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD34+ cell were seeded at 0.5 – 1 × 106/mL in a 6 well plate containing Alpha MEM (Sigma), FBS (Stem Cell Technologies), Glutamine (Gibco), BSA (Sigma), human erythropoietin (Amgen), β-mercaptoethanol (Gibco), dexamethasone (American Regent Laboratories), holo-transferrin (American Regent Laboratories) and human recombinant SCF (Sigma). Cells were counted and fed from day 4 to 10 with the same EC differentiation medium. This differentiation process was used for in vitro modeling of erythropoiesis and VCN determination. For CD34+ cells pre- and post-transduction, CD34+ cells were plated at 500 cells per plate in MethoCultH4435 Enriched (StemCell Technology). BFU-E, CFU-M, CFU-G and CFU-GM were distinguished and counted after 14 – 16 days as per as per manufacturers’ directions.
+ Open protocol
+ Expand
10

Osteotropic Breast and Prostate Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The endocannabinoid 2AG and MAGL inhibitor JZL184 were purchased from Tocris Biosciences (Bristol, UK). The parental human breast MDA-MB-231, prostate PC3, osteosarcoma KHOS and Saos-2 were purchased from ATCC (Manassas, VA). The mouse osteosarcoma cells MOSJ were originally purchased from ATCC (Manassas, VA) and were a kind gift from Professor Dominique Heymann (INSERM, University of Nantes, France). The osteotropic human breast cancer cell line MDA-MB-231-BT (MDA-231-BT) was generated by Dr. Nadia Rucci (University of L'Aquila, Italy) and the osteotropic human prostate cancer cell line PC3-BT was a kind gift by Dr. Ning Wang (University of Sheffield, UK). Single cell clones of MDA-MB-231 were expanded and injected into the left ventricle of 4-week-old female BALB/c-nu/nu mice. A clone that generated bone-only lesions with significant osteolysis in 8-weeks was used [[34] (link), [35] , [36] (link), [37] (link)]. Tissue culture medium (D-Modified Eagle Medium (MEM) and alpha-MEM) was obtained from Sigma-Aldrich (Dorset, UK). All primary antibodies were purchased from Cell Signalling Biotechnology (MA, USA) except rabbit anti-actin, which was obtained from Sigma-Aldrich (Dorset, UK). Mouse macrophage colony stimulating factor (M-CSF) was obtained from R&D Systems (Abingdon, UK) and receptor activator of NFκB ligand (RANKL) was a gift from Patrick Mollat (Galapagos SASU, France).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!